177 related articles for article (PubMed ID: 8521613)
1. Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas.
Sivaparvathi M; Yamamoto M; Nicolson GL; Gokaslan ZL; Fuller GN; Liotta LA; Sawaya R; Rao JS
Clin Exp Metastasis; 1996 Jan; 14(1):27-34. PubMed ID: 8521613
[TBL] [Abstract][Full Text] [Related]
2. Expression and the role of cathepsin H in human glioma progression and invasion.
Sivaparvathi M; Sawaya R; Gokaslan ZL; Chintala SK; Rao JS
Cancer Lett; 1996 Jun; 104(1):121-6. PubMed ID: 8640738
[TBL] [Abstract][Full Text] [Related]
3. Overexpression and localization of cathepsin B during the progression of human gliomas.
Sivaparvathi M; Sawaya R; Wang SW; Rayford A; Yamamoto M; Liotta LA; Nicolson GL; Rao JS
Clin Exp Metastasis; 1995 Jan; 13(1):49-56. PubMed ID: 7820956
[TBL] [Abstract][Full Text] [Related]
4. Expression of cathepsin D during the progression of human gliomas.
Sivaparvathi M; Sawaya R; Chintala SK; Go Y; Gokaslan ZL; Rao JS
Neurosci Lett; 1996 Apr; 208(3):171-4. PubMed ID: 8733297
[TBL] [Abstract][Full Text] [Related]
5. Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo.
Sawaya RE; Yamamoto M; Gokaslan ZL; Wang SW; Mohanam S; Fuller GN; McCutcheon IE; Stetler-Stevenson WG; Nicolson GL; Rao JS
Clin Exp Metastasis; 1996 Jan; 14(1):35-42. PubMed ID: 8521615
[TBL] [Abstract][Full Text] [Related]
6. Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas.
Rao CN; Lakka SS; Kin Y; Konduri SD; Fuller GN; Mohanam S; Rao JS
Clin Cancer Res; 2001 Mar; 7(3):570-6. PubMed ID: 11297250
[TBL] [Abstract][Full Text] [Related]
7. Lysosomal enzymes, cathepsins in brain tumour invasion.
Levicar N; Strojnik T; Kos J; Dewey RA; Pilkington GJ; Lah TT
J Neurooncol; 2002 May; 58(1):21-32. PubMed ID: 12160137
[TBL] [Abstract][Full Text] [Related]
8. Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas.
Rao JS; Yamamoto M; Mohaman S; Gokaslan ZL; Fuller GN; Stetler-Stevenson WG; Rao VH; Liotta LA; Nicolson GL; Sawaya RE
Clin Exp Metastasis; 1996 Jan; 14(1):12-8. PubMed ID: 8521611
[TBL] [Abstract][Full Text] [Related]
9. Age-related changes in activities and localizations of cathepsins D, E, B, and L in the rat brain tissues.
Nakanishi H; Tominaga K; Amano T; Hirotsu I; Inoue T; Yamamoto K
Exp Neurol; 1994 Mar; 126(1):119-28. PubMed ID: 8157122
[TBL] [Abstract][Full Text] [Related]
10. Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis.
Mikkelsen T; Yan PS; Ho KL; Sameni M; Sloane BF; Rosenblum ML
J Neurosurg; 1995 Aug; 83(2):285-90. PubMed ID: 7542317
[TBL] [Abstract][Full Text] [Related]
11. Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas.
Mai J; Sameni M; Mikkelsen T; Sloane BF
Biol Chem; 2002 Sep; 383(9):1407-13. PubMed ID: 12437133
[TBL] [Abstract][Full Text] [Related]
12. Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness in vitro.
Gole B; Durán Alonso MB; Dolenc V; Lah T
Pathol Oncol Res; 2009 Dec; 15(4):711-23. PubMed ID: 19434518
[TBL] [Abstract][Full Text] [Related]
13. Assessment of cathepsin L activity by use of the inhibitor CA-074 compared to cathepsin B activity in human lung tumor tissue.
Werle B; Ebert W; Klein W; Spiess E
Biol Chem Hoppe Seyler; 1995 Mar; 376(3):157-64. PubMed ID: 7612192
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin (HAI-2/PB) in human glioblastomas: implication for anti-invasive role of HAI-2/PB in glioblastoma cells.
Hamasuna R; Kataoka H; Meng JY; Itoh H; Moriyama T; Wakisaka S; Koono M
Int J Cancer; 2001 Aug; 93(3):339-45. PubMed ID: 11433397
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin D is a potential serum marker for poor prognosis in glioma patients.
Fukuda ME; Iwadate Y; Machida T; Hiwasa T; Nimura Y; Nagai Y; Takiguchi M; Tanzawa H; Yamaura A; Seki N
Cancer Res; 2005 Jun; 65(12):5190-4. PubMed ID: 15958563
[TBL] [Abstract][Full Text] [Related]
16. Procathepsin L-specific antibodies that recognize procathepsin L but not cathepsin L.
Ishidoh K; Takeda-Ezaki M; Kominami E
FEBS Lett; 1993 May; 322(1):79-82. PubMed ID: 8482373
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical and biochemical study of a cathepsin B-like proteinase in human colonic cancers.
Keppler D; Fondanèche MC; Dalet-Fumeron V; Pagano M; Burtin P
Cancer Res; 1988 Dec; 48(23):6855-62. PubMed ID: 3180094
[TBL] [Abstract][Full Text] [Related]
18. Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival.
Strojnik T; Røsland GV; Sakariassen PO; Kavalar R; Lah T
Surg Neurol; 2007 Aug; 68(2):133-43; discussion 143-4. PubMed ID: 17537489
[TBL] [Abstract][Full Text] [Related]
19. Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis.
Levicar N; Dewey RA; Daley E; Bates TE; Davies D; Kos J; Pilkington GJ; Lah TT
Cancer Gene Ther; 2003 Feb; 10(2):141-51. PubMed ID: 12536203
[TBL] [Abstract][Full Text] [Related]
20. Expression of cysteine protease inhibitors in human gliomas and meningiomas.
Sivaparvathi M; McCutcheon I; Sawaya R; Nicolson GL; Rao JS
Clin Exp Metastasis; 1996 Sep; 14(4):344-50. PubMed ID: 8878408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
